Journal article
UDP glucuronosyltransferase mRNA levels in human liver disease
M Congiu, ML Mashford, JL Slavin, PV Desmond
Drug Metabolism and Disposition | AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS | Published : 2002
DOI: 10.1124/dmd.30.2.129
Abstract
The UDP glucuronosyltransferases (UGT) are a family of enzymes in which substrates include drugs, xenobiotics, and products of endogenous catabolism. The main source of most UGT enzymes is the liver, a major organ in the detoxification and inactivation of compounds. Previous studies have indicated that glucuronidation, as measured by pharmacokinetic studies, is relatively spared in liver disease. Because UGT activity toward most substrates is the result of metabolism by different isoforms with overlapping specificities, these studies may not indicate the effect of disease on the levels of individual isoforms. We sought to extend these studies to the measurement of mRNA for individual isoform..
View full abstract